HEEeeyyy!! Look at all the millions in grants NOT going to Yale or New York Medical College !!
kathleen
patrick.f...@usdoj.gov, model...@sbcglobal.net,
jdr...@nejm.org, let...@courant.com, Jgerb...@cdc.gov,
len...@courant.com, steven....@po.state.ct.us,
con...@po.state.ct.us, executiv...@nytimes.com, managing-
edi...@nytimes.com, news...@nytimes.com, the-...@nytimes.com,
biz...@nytimes.com, for...@nytimes.com, me...@nytimes.com,
nati...@nytimes.com, spo...@nytimes.com, dv...@cdc.gov,
brigidc...@optonline.net, tr...@hotmail.com, ubi...@courant.com,
ma...@concentric.net, camp...@courant.com, jhorn...@fff.org,
thomas...@usdoj.gov, edi...@commondreams.org, kur...@washpost.com,
georg...@washpost.com, hor...@courant.com,
commissi...@po.state.ct.us, cohen...@aol.com,
FalN...@aol.com, brans...@comcast.net, vts...@comcast.net,
mcne...@aol.com, o...@po.state.ct.us, da...@davila-dilzer.com,
scott....@po.state.ct.us, govern...@po.state.ct.us,
attorney...@po.state.ct.us, randall...@usdoj.gov
Cc: fra...@ucia.gov, dr-ahma...@president.ir,
eugener...@washpost.com, hor...@courant.com,
bmi...@newstimes.com, tr...@hotmail.com, rast...@aol.com,
billc...@gmail.com, thomas...@usdoj.gov, amcg...@rms-law.com,
rjmu...@aol.com, paulcrai...@yahoo.com,
sidney_b...@yahoo.com, criminal...@usdoj.gov,
karla.d...@usdoj.gov, christophe...@usdoj.gov
Subject: HEEeeyyy!! Look at all the millions in grants NOT going
to Yale or New York Medical College
Date: Sep 19, 2007 1:49 PM
Why fund more "Cryme Disease?" Yale is an international embarrassment
and Russia knows ***all about*** what their stupid little defectors
are doing at
New York Medical College:
http://www.actionlyme.org/IDSA_CYST_VIABLE.htm
================================
http://news.google.com/news?hl=en&ned=&q=NIH&btnG=Search+News
16 area scientists awarded NIH grants for innovative study
Lisa Feldman Barrett, a Boston College professor, won a Pioneer Award.
Lisa Feldman
Barrett, a Boston College professor, won a Pioneer Award.
By Elizabeth Cooney, Globe Correspondent | September 19, 2007
Boston-area scientists made a strong showing in two government grant
programs designed
to spur innovative medical research in an era of tight federal
funding.
Article Tools
* Breaking News Alerts
Sixteen of 41 winners announced yesterday by the National Institutes
of Health are
from Greater Boston. Half of this year's 12 recipients of the
prestigious Pioneer
Award work at Boston-area hospitals or universities and 10 of 29 New
Innovator awards
are going to investigators in Boston or Cambridge. Pioneer grant
winners receive
$2.5 million and New Innovators get $1.5 million, all over five years.
"I think it's a real testimony to the area," Jeremy M. Berg, director
of the National Institute of General Medical Sciences, said in an
interview. "Boston
is certainly known for having a large number of high-quality
educational institutions,
like Harvard and MIT, but also many others. These are very much
individual-based
awards, though, so it's really a reflection of the ability of these
institutions
to recruit outstanding people."
This is Boston's best showing in the Pioneer competition, now in its
fourth
year. Only California has come close to Massachusetts' success,
accounting for
six of the 13 Pioneer winners in 2005. In 2004, Harvard University
researchers took
home two of nine grants. In 2005, one winner was from Massachusetts,
and last year
four of 13 scientists were from the state. This is the first year for
the New Innovator
grants.
Berg runs the two grant programs under an NIH initiative intended to
support bold
and unconventional research that could have a big payoff but also has
a higher than
usual risk of failure and is therefore less likely to receive approval
through the
traditional grant process.
While the Pioneer awards go to researchers at any point in their
careers, the New
Innovator awards are limited to scientists who are within 10 years of
finishing
their doctoral degrees or clinical training and who have not yet won
NIH grants
for their independent research.
Younger scientists have been waiting longer to get their first grants,
from an average
age of mid-30s about 10 years ago to their 40s in recent years, a sign
of increased
competition for government funding for science that has been declining
in real dollars.
The NIH budget doubled from 1998 to 2003 but has been flat since.
The New Innovator competition drew 2,200 applications, Berg said,
compared with
450 for the Pioneer awards.
"We expected there would be a strong response, but not this strong,"
he
said, adding that the number of applicants demonstrates the need for a
program that
supports riskier work.
"The motivation for the program was to find a good way to get
outstanding young
scientists funded earlier in their careers and to encourage people to
really work
on things they were most excited about rather than being conservative"
and
working on things that have a better chance of getting funded, he
said.
Nir Hacohen, of Massachusetts General Hospital, will use his New
Innovator award
to study how the immune system senses infectious agents and turns on a
response
specific to viruses, bacteria, or fungi. He said the grants are needed
for science
to make advances.
"Clearly people are starving for this kind of award," the 40-year-old
researcher said.
Konrad Hochedlinger, 31, a scientist at Mass. General and Harvard Stem
Cell Institute,
said his Innovator award will help him quickly advance his work in the
fast-moving
field of stem cell research, without having to wait to win a regular
NIH grant.
He has created a new approach based on work by Japanese scientists to
reprogram
adult cells into embryonic stem cells.
Lisa Feldman Barrett, a Boston College psychology professor who won a
Pioneer grant,
will study the neuroanatomy of emotions such as anger and fear,
pursuing a theory
that does not fit conventional models.
She said the traditional funding process "is a very risk-averse
strategy, and
if people have limited funds it's a good idea, but it can slow
innovation and
progress."
These are the other Boston-area winners.
Pioneer Award: Dr. Emery N. Brown, Mass. General and Massachusetts
Institute of
Technology; James J. Collins, Boston University; Takao K. Hensch,
Children's
Hospital Boston; Dr. Frances E. Jensen, Children's Hospital
Boston;Gina Turrigiano,
Brandeis University
New Innovator Award: Ed Boyden, MIT; Mehmet Fatih Yanik, MIT; Alan
Jasanoff, MIT;
Dr. Sarah Fortune, Harvard School of Public Health; Alan Saghatelian,
Harvard University;
Dr. Levi A. Garraway, Dana-Farber Cancer Institute; Ekaterina
Heldwein, Tufts University
School of Medicine; Dr. Mark D. Johnson, Brigham and Women's Hospital
© Copyright 2007 Globe Newspaper Company.
===========================
JHU receives $93 million grant from NIH:
http://www.baltimoresun.com/news/health/bal-nih0918,0,1471450.story
Award meant to help school turn promising medical discoveries into
tangible treatments
By Jonathan D. Rockoff | Sun reporter
4:14 PM EDT, September 18, 2007
Article tools
WASHINGTON - The National Institutes of Health awarded $93 million to
Johns Hopkins
University today to turn promising medical discoveries into tangible
treatments.
The five-year grant helps establish the Johns Hopkins Institute for
Clinical and
Translational Research, which will work with Baltimore-area hospitals
and clinics
to push discoveries into medical practice.
The institute will also train researchers in the field, and it will
share what works
with the consortium of 24 other academic health centers receiving
awards.
"They will bring a lot of firepower to the consortium," said Dr.
Barbara
M. Alving, director of the National Center for Research Resources, the
department
at NIH issuing the awards.
Johns Hopkins is among the country's leading recipients of NIH
funding, with
more than a half-billion dollars in research grants each year.
More articles
===============================================
U of Michigan gets 55 million:
University of Michigan receives $55 million NIH grant
http://www.webwire.com/ViewPressRel.asp?aId=48141
(WebWire) 9/19/2007 11:36:06 AM
University matches grant for major investment in human research
resources and training
ANN ARBOR, MI - National Institutes of Health Director Elias A.
Zerhouni, M.D.,
has announced that the University of Michigan will receive a $55
million Clinical
and Translational Science Award. The CTSAs are part of a national
initiative to
encourage and speed collaboration and interdisciplinary research for
therapies that
improve human health.
The announcement places U-M with 23 other academic medical centers
around the country
who are members of an expanding national CTSA consortium. Its mission
is to transform
how clinical and translational research is conducted. When fully
implemented in
2012, about 60 institutions will be linked together to energize the
discipline of
clinical and translational science.
"As the consortium grows, we are fulfilling our charge to transform
clinical and
translational research," said Zerhouni. "Through collaboration and
leadership, these
sites are serving as discovery engines that can rapidly translate
research into
prevention strategies and clinical treatments for the people who need
them. The
CTSA consortium also represents our investment in the future as it
prepares the
next generation of clinical researchers to meet tomorrow's health care
challenges."
This five-year grant, the third largest NIH award in the University's
history and
the largest NIH award to the Medical School in its history, builds on
previous NIH
investments to expand innovative programs and services in clinical
research infrastructure
and education. Key participants include the Medical School, Schools of
Business,
Dentistry, Pharmacy, Nursing, Public Health, the College of
Engineering, Division
of Kinesiology, the Life Sciences Institute and the Institute for
Social Research.
"The Medical School and the Hospitals and Health Centers have, and
will continue
to play, leadership roles in the success of this CTSA award, which
could only be
achieved through the broad support from schools, colleges and units
across our institution,"
says Robert P. Kelch, M.D., U-M executive vice president for medical
affairs and
CEO, U-M Health System. "We have an incredibly strong institutional
commitment that
includes a nearly one-to-one funding match from many of the
University's schools
and colleges. The energy sweeping through our biology, clinical
medicine, dentistry,
nursing, pharmacy, public health, engineering and genomic units is
palpable."
The U-M's Michigan Institute for Clinical and Health Research,
launched last November,
is the administrative umbrella for this grant. Led by Dan Clauw, M.D.,
professor
of internal medicine, MICHR is creating partnerships among the
relevant units of
the University, the NIH, external industry partners, and the community
for both
research and education.
"A CTSA is the superhighway of the NIH roadmap - it's the ultimate
resource an institution
needs to really deliver cures and treatments to our patients. The
University has
been building infrastructure for nearly five years. As a result we are
ready to
use the CTSA to help people do the best research, as well as excite
and attract
people who weren't previously thinking about a career in clinical or
translational
research," Clauw says.
MICHR programs already in place include a Pilot and Collaborative
Grant Program
for Translational and Clinical Research. In August, MICHR awarded $3.6
million in
its first round, the largest ever interdisciplinary grant program at
the U-M. In
addition to funds from MICHR itself, 24 different departments,
colleges or units
at the U-M provided funds to encourage collaboration and
interdisciplinary research
for therapies that improve human health.
"We're already seeing this program do what we intended: incent,
catalyze and establish
collaborations in ways that haven't been tried before," Clauw says.
Engage, a Web site developed for potential participants - and
referring physicians
recruiting volunteers for U-M clinical studies - is another successful
MICHR program.
Started in 2005, the site lets prospective volunteers register their
interest, search
for new studies at any time and update personal profiles.
"Reaching out to the community is such an important charge from the
CTSA consortium.
To develop Engage, we involved members of the community in deciding
what information
the website should have, and how best to present it," says Dorene
Markel, MICHR
managing director. "This is one of a number of outreach programs that
aim to build
trust in the community so members feel comfortable partnering with our
researchers."
A broad array of training programs are already in place at MICHR,
reaching medical,
public health, engineering and allied health undergraduates, pre-and
post-doctoral
students, and young basic science and clinical investigators just
beginning their
careers. This rich educational environment will educate and develop
the next generation
of researchers.
MICHR's Community Advisory Board involves community partners from
throughout the
area, including Ypsilanti, Flint and Detroit, in order to identify and
execute major
outreach efforts throughout the state so that research taking place
under the auspices
of the CTSA will directly benefit the people of Michigan.
"Even with this infrastructure already in place, there is much to do.
For example,
moving to a model of team science - there's no better place than U-M
to do this.
We have an existing culture of successful collaboration and we have
Top 10 graduate
schools in every field related to health. The potential is great,"
Clauw says.
The CTSA initiative grew out of the NIH commitment to re-engineer the
clinical research
enterprise, one of the key objectives of the NIH Roadmap for Medical
Research. Funding
for the CTSA initiative comes from redirecting existing clinical and
translational
programs and from Roadmap funds. Total funding for these new awards
will be approximately
$577 million. This total represents a nearly five-year budget period.
For more information on the current members and the new grantees
follow this link.
Written by Mary Beth Reilly
=================================================
U Madison Recieves 41 million dollars from the NIH:
http://www.bizjournals.com/milwaukee/stories/2007/09/17/daily16.html
UW-Madison institute lands $41M NIH grant
The Business Journal of Milwaukee - 3:11 PM CDT Tuesday, September 18,
2007
The University of Wisconsin-Madison's new Institute for Clinical and
Translational
Research will receive $41 million over five years from the National
Institutes of
Health to advance biomedical and health sciences discoveries at the
university.
UW-Madison said Tuesday that the NIH grant is one of the largest in
the history
of the UW School of Medicine and Public Health.
The primary goal is to find ways of better moving biomedical and
health sciences
discoveries into practical use in health care providers' offices,
clinics and
hospitals, where the new knowledge can be used most rapidly and
effectively to improve
peoples' health.
The Institute for Clinical and Translational Research will address
clinical and
translational research in Wisconsin by first building a network of key
partners
from across campus and around the state. Representatives of the four
UW-Madison
health sciences schools -- medicine and public health, nursing,
pharmacy and veterinary
medicine -- and the College of Engineering are involved, along with
the Marshfield
Clinic.
With an infrastructure in place, the institute will expand training
programs and
coordinate an array of resources and services for both new and
established investigators.
The NIH made the grant under its "Roadmap for Medical Research"
initiative,
which calls for the establishment of academic homes for clinical and
translational
research.
In keeping with the NIH plan, the agency began a Clinical and
Translational Science
Awards program in 2006. Twelve academic medical centers received the
first round
of CTSA grants; UW-Madison is among the 12 institutions that won
grants in the second
round.
===========================================
Hopkins to receive NIH funds for center
$40 million to aid turning research into treatment
By Chris Emery | Sun reporter
September 19, 2007
The Johns Hopkins University will receive about $40 million in new
federal funds
over the next five years to help translate promising research into
medical treatments,
school officials announced yesterday.
The funds, from the National Institutes of Health, will be used for a
new center:
the Johns Hopkins Institute for Clinical and Translational Research.
The center will be part of a national consortium of 24 institutions
that NIH began
funding last year in hopes that collaboration among scientists will
speed the development
of medical breakthroughs.
Hopkins officials said the university received one of the largest
awards among the
12 new institutions added to the consortium this year.
"As a powerhouse of research, Johns Hopkins will be a very strong
partner in
the consortium," said Dr. Barbara M. Alving, director of the NIH's
National
Center for Research Resources.
The NIH award totals about $100 million, but more than half of it
replaces funding
for research projects that were set to be renewed, said Dr. Daniel
Ford, vice dean
for clinical investigation at Johns Hopkins Medicine.
Still, the money represents a shift in NIH's priorities, led by
director Dr.
Elias A. Zerhouni, toward promoting translational research, the kind
of scientific
enterprise that produces tangible results for patients.
Ford said the structure of the funding will force Hopkins and other
institutions
to work together and become more organized in their approach to
medical science.
The new system also will encourage collaboration among scientists who
focus on basic
laboratory experiments and clinical researchers who work with
patients.
"We act in an uncoordinated ways sometimes," Ford said. "We may have
one researcher at Bayview and one at Johns Hopkins Hospital who are
working on a
similar problem but don't deal with each other."
In addition to funding experiments, Hopkins plans to use the money to
build an infrastructure
that encourages collaboration, Ford said. The institution also plans
to train scientists
how to lead research efforts involving people from different sub-
specialties.
"We evolve into these highly technical units," he said, "but we also
need the infrastructure and people whose job it is to cross those
bridges."
NIH's Alving stressed that Hopkins will share what it finds to work
best in
translating research into practice with the 23 other academic health
centers receiving
the funds.
"They will bring a lot of firepower to the consortium," she said of
Hopkins.
Ford said he hopes the funding strategy will strengthen the medical
science establishment
in the United States, but he is waiting to see if the mandated
collaboration works.
"It's a big idea and a big plan," Ford said. "And hopefully,
it won't collapse under its own weight."
chris...@baltsun.com
Sun reporter Jonathan D. Rockoff contributed to this article.
More articles